Oxinorm



Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 21.4%
Lymphoma 16.9%
Cancer Pain 16.3%
Constipation 6.0%
Herpes Zoster 4.8%
Hypertension 4.8%
Pain 4.4%
Prophylaxis 4.0%
Metastatic Renal Cell Carcinoma 3.4%
Pyrexia 3.2%
Chronic Pain 2.0%
Abdominal Distension 1.6%
Fluid Replacement 1.6%
Neutropenia 1.6%
Renal Cell Carcinoma 1.6%
Gastritis 1.5%
Decreased Appetite 1.2%
Palmar-plantar Erythrodysaesthesia Syndrome 1.2%
Peripheral Sensory Neuropathy 1.2%
Breast Cancer 1.1%
Thrombocytopenia 32.1%
Vomiting 23.2%
Ileus 5.4%
Dermatitis Acneiform 3.6%
Platelet Count Decreased 3.6%
Somnolence 3.6%
Treatment Noncompliance 3.6%
Urinary Retention 3.6%
Death 1.8%
Delirium 1.8%
Depressed Level Of Consciousness 1.8%
Enterocolitis 1.8%
Faecaloma 1.8%
Gastritis 1.8%
Hallucination 1.8%
Insomnia 1.8%
Movement Disorder 1.8%
Myocardial Infarction 1.8%
Neoplasm Malignant 1.8%
Ovarian Cancer 1.8%
Concomitant
Prophylaxis 18.7%
Cancer Pain 16.2%
Multiple Myeloma 8.7%
Constipation 6.8%
Plasma Cell Myeloma 6.6%
Product Used For Unknown Indication 6.5%
Metastatic Renal Cell Carcinoma 4.7%
Pain 3.9%
Hypertension 3.8%
Renal Cell Carcinoma 3.3%
Drug Use For Unknown Indication 3.0%
Colorectal Cancer 3.0%
Metastases To Bone 2.6%
Nausea 2.5%
Breast Cancer 2.2%
Insomnia 2.2%
Bronchitis 1.4%
Back Pain 1.3%
Gastritis 1.2%
Analgesic Therapy 1.2%
Interstitial Lung Disease 11.1%
White Blood Cell Count Decreased 10.0%
Pyrexia 7.7%
Vomiting 6.9%
Pneumonia 6.0%
Rash 6.0%
Malignant Neoplasm Progression 5.4%
Anaemia 4.6%
Sepsis 4.3%
Wrong Technique In Drug Usage Process 4.3%
Hepatic Function Abnormal 4.0%
Malaise 4.0%
Palmar-plantar Erythrodysaesthesia Syndrome 4.0%
Renal Cell Carcinoma 4.0%
Tumour Haemorrhage 3.7%
Decreased Appetite 2.9%
Diarrhoea 2.9%
Disseminated Intravascular Coagulation 2.9%
Tracheobronchitis Mycoplasmal 2.9%
Altered State Of Consciousness 2.6%